Whitehawk Therapeutics, Inc. Common Stock WHWK Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$22.19M+4.5% | -$23.25M-31.0% | -$17.75M+66.3% | -$52.62M-172% | $73.02M+500% | ||
| $1K0.0% | $1K-82.1% | $5.6K-63.4% | $15.3K-73.2% | $57K+21.3% | ||
| $2.19M-8.2% | $2.39M-12.1% | $2.72M-12.0% | $3.09M+83.8% | $1.68M-9.4% | ||
| $0— | $0+100% | -$177K— | $0-100% | $87.44M— | ||
| $0— | —— | —— | —— | $1M— | ||
| $0— | —— | —— | —— | -$170K-7.6% | ||
| -$3.49M-175% | $4.67M+374% | $985K+136% | -$2.71M-378% | $975K— | ||
| -$163K— | —— | —— | $880K+872% | -$114K+24.5% | ||
| $0— | —— | —— | —— | -$202K— | ||
| $0— | —— | —— | —— | -$89K+31.0% | ||
| -$22.21M-28.9% | -$17.23M-12.1% | -$15.38M+71.0% | -$52.96M-346% | -$11.86M+21.2% | ||
| $0— | —— | —— | $1K-99.8% | $551K+196% | ||
| $19.19M-16.3% | $22.92M-75.5% | $93.56M+190% | $32.22M— | $0— | ||
| $38.62M-2.9% | $39.76M+1,890% | $2M-41.1% | $3.39M-76.9% | $14.69M+10.3% | ||
| $0— | —— | —— | —— | $101.36M— | ||
| $19.43M+15.3% | $16.85M+118% | -$91.63M— | —— | $115.5M+779% | ||
| $0— | —— | —— | $5K-76.2% | $21K— | ||
| $0-100% | $25K— | —— | —— | $95.2M+179,525% | ||
| -$2.78M— | —— | —— | —— | $198.84M+10,750% | ||
| $347K-58.2% | $831K+15.9% | $717K+35,950% | -$2K+89.5% | -$19K-110% | ||
| $1K— | —— | $5.6K-63.4% | $15.3K-73.2% | $57K— | ||
| $0— | $0+100% | -$177K— | $0-100% | $87.44M— | ||
| $0— | —— | —— | —— | -$89K+31.0% | ||
| -$1.47M-492% | $375K-61.1% | $965K+784% | -$141K+81.6% | -$765K-268% | ||
| $0— | —— | —— | —— | $74K-35.7% | ||
| $0— | —— | —— | —— | $101.36M— | ||
| $38.62M-2.9% | $39.76M+1,890% | $2M-41.1% | $3.39M-76.9% | $14.69M+10.3% | ||
| $0— | —— | —— | $803K-83.3% | $4.82M— | ||
| $0— | —— | —— | —— | $100M— | ||
| $30K— | —— | —— | —— | $167K+377% | ||
| $0— | —— | —— | —— | -$89K+31.0% | ||
| $0— | —— | —— | —— | $632K— | ||
| -$22.21M-28.9% | -$17.23M-12.1% | -$15.38M+71.0% | -$52.96M-327% | -$12.42M+18.5% | ||
| -$22.21M-28.9% | -$17.23M-12.1% | -$15.38M+71.0% | -$52.96M-327% | -$12.42M+18.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Whitehawk Therapeutics, Inc. Common Stock generate?
- Whitehawk Therapeutics, Inc. Common Stock (WHWK) generated -$107.8M in operating cash flow over the trailing twelve months.
- What is Whitehawk Therapeutics, Inc. Common Stock's free cash flow?
- After $738.0K of capital expenditures, Whitehawk Therapeutics, Inc. Common Stock's free cash flow was -$107.8M over the trailing twelve months, down 102.5% year over year.
- Where does Whitehawk Therapeutics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Whitehawk Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.